Cellares

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) that applies an Industry 4.0 approach to mass manufacture the “living drugs” of the 21st century. The company develops and operates integrated technologies and automated manufacturing systems for cell therapies to accelerate access to life‑saving treatments. By combining development, engineering, and scalable production, Cellares aims to simplify and industrialize cell therapy manufacturing. It positions itself as a platform-driven partner for bringing next‑generation cell therapies to patients more reliably and at scale.